SCHEMBL28768366

SCHEMBL28768366

NC(=O)OC1CCOc2ccc(SBr)cc21

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.34
▸ NPC1 O15118 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ HCRTR2 O43614 1/20 0.31
▸ LMNA P02545 1/20 0.30
▸ ATM Q13315 1/20 0.30
▸ POLB P06746 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28768290 0.90 TSHR (0.34) TSHRNPC1TP53PKMRAB9A
SCHEMBL28768256 0.83 HCRTR2 (0.39) TSHRNPC1PKMRAB9ASMN1; SMN2
SCHEMBL28768358 0.83 ADRA2A (0.42) TSHRNPC1RAB9AHCRTR2LMNA
SCHEMBL28768179 0.81 TSHR (0.43) TSHRNPC1TP53RAB9ASMN1; SMN2
SCHEMBL28768087 0.76 KDM4C (0.38) TSHRNPC1RAB9ASMN1; SMN2LMNA
SCHEMBL28768377 0.76 HDAC3 (0.39) RAB9ASMN1; SMN2LMNAATM
SCHEMBL28768233 0.76 MAPT (0.41) NPC1TP53RAB9ASMN1; SMN2HCRTR2
SCHEMBL28768299 0.76 TSHR (0.41) TSHRNPC1TP53RAB9ASMN1; SMN2
SCHEMBL23362601 0.75 ADRA2A (0.33) —
SCHEMBL3747981 0.75 MAP3K14 (0.47) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114641477-B Compounds having inhibitory activity on glucosylceramide synthase or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the same 柳韩洋行 2024-03-12 — — CN disclosed
CN-114641477-A Novel compound having inhibitory activity against glucose ceramide synthase or pharmaceutically acceptable salt thereof, method for preparing same, and pharmaceutical composition comprising same 柳韩洋行 2022-06-17 — — CN disclosed
Send feedback